Image

Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy

Intensive Preoperative Speech Rehabilitation in Drug-Resistant Temporal Epilepsy

Recruiting
16 years and older
All
Phase N/A

Powered by AI

Overview

Out of 30,000 new cases per year in France, 30% of epileptic patients are drug-resistant. Neurosurgery, which consists in resecting the epileptogenic zone, is the only chance of cure. In the case of temporal epilepsy of the language-dominant hemisphere (TLE), this procedure presents a high risk of increasing cognitive difficulties and may even be contraindicated for this reason alone. The difficulties found are impairments in lexical access (anomia) and verbal memory and affect more than 60% of patients . Preoperative cognitive rehabilitation could influence brain plasticity mechanisms but there are currently no recommendations on this topic. In this context, the investigators have developed a speech rehabilitation procedure specific to the needs of ELTPR patients. They rely on cognitive hypotheses explaining the disorders but also on models of rehabilitation-induced neural plasticity likely to improve cognitive reserve before surgery. The investigators hypothesize that preoperative cognitive language rehabilitation in ELTPR patients may decrease surgical risk and improve postoperative language prognosis.

The primary objective is to demonstrate the protective efficacy of preoperative speech rehabilitation on language performance postoperatively.

Eligibility

Inclusion Criteria:

  1. Patient 16 years of age and older,
  2. Patient whose epileptogenic area involves the temporal structures of the hemisphere specialized for language,
  3. Patient whose hemispheric specialization for language is known
  4. Patient who accepts resective surgery such as anterior temporal lobectomy and whose planned surgery date is compatible with the study,
  5. Patient with a known NTB score
  6. Patient who has signed an informed consent or patient whose parents or legal guardians have signed the informed consent (or a single parent or legal guardian if applicable)
  7. Patient whose first language is French (1st language learned by the patient),
  8. Patient declaring to be familiar with the use of a computer and having access to an internet connection from home
  9. Patient affiliated or benefiting from a social security system.

Exclusion Criteria:

  1. Patient with a speech disorder that may impair intelligibility and compromise the use of the interface;
  2. Patient with an uncorrected hearing impairment,
  3. Patients with a total intelligence quotient (IQ) <70 (assessed in the context of care, in the year preceding the surgical procedure)
  4. Patients who are pregnant, nursing, deprived of liberty, under guardianship or curatorship.

Study details
    Epilepsy
    Anomia
    Temporal Lobe Epilepsy

NCT05609084

Assistance Publique Hopitaux De Marseille

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.